alpha-aminopyridine has been researched along with zstk474 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dan, S; Kong, D; Yamazaki, K; Yamori, T | 1 |
| Gao, J; Jiang, X; Liu, F; Qian, Y; Wang, Y; Wu, X | 1 |
2 other study(ies) available for alpha-aminopyridine and zstk474
| Article | Year |
|---|---|
In vitro multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CA.
Topics: Aminopyridines; Antineoplastic Agents; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Humans; Imidazoles; Indazoles; Morpholines; Mutation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinolines; Sulfonamides; Triazines | 2014 |
PIK3C3 regulates the expansion of liver CSCs and PIK3C3 inhibition counteracts liver cancer stem cell activity induced by PI3K inhibitor.
Topics: Aminopyridines; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Female; Humans; Liver Neoplasms; Mice; Mice, Nude; Neoplastic Stem Cells; Phosphoinositide-3 Kinase Inhibitors; Pyrimidines; Random Allocation; Transfection; Triazines; Xenograft Model Antitumor Assays | 2020 |